Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 18 min ago
Peer-reviewedCC BY-NC-NDJournal of immunotherapy and precision oncology

Moving Beyond the Plateau in Immune Checkpoint Inhibition-The Imperative of Early Referral and Precision Strategies.

  • Razelle Kurzrock1,2
  1. 1Medical College of Wisconsin, Milwaukee, WI, USA.
  2. 2WIN Consortium, Paris, France.
Read full textPDFDOICite

Related

  1. Rethinking research partnership strategies in Africa amid US budget cuts: A critical imperative
    Kaymarlin Govender, Patrick Nyamaruze, Christopher Jimu
    Global health research and policyPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
  2. 418 B cell regulation of anti-PD-1 immune checkpoint inhibition
    Martin J Cannon, Richard A Connor, Lisa R Williams
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  3. Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner.
    Zhe Fu, Victoria Jackson-Patel, Kathryn Farrand +7
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  4. Amygdala metabolic activity on FDG PET is associated with survival, response to immune checkpoint inhibition, and tumor immune signaling in non-small cell lung cancer
    B. K. Geist, C. Vraka, C. T. S. Mertel +27
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. TALAVE in Breast Cancer: BRCA1/2 Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement
    F. Lynce, K. Shimada, C. Isaacs +18
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv

Cite

BibTeXRIS
BibTeX
@article{kurzrock2026moving,
  title = {{Moving Beyond the Plateau in Immune Checkpoint Inhibition-The Imperative of Early Referral and Precision Strategies.}},
  author = {Razelle Kurzrock},
  journal = {Journal of immunotherapy and precision oncology},
  year = {2026},
  month = oct,
  doi = {10.36401/jipo-26-x6},
  url = {https://europepmc.org/article/MED/42872036},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Moving Beyond the Plateau in Immune Checkpoint Inhibition-The Imperative of Early Referral and Precision Strategies.
AU  - Razelle Kurzrock
PY  - 2026
DA  - 2026/10/05
JO  - Journal of immunotherapy and precision oncology
DO  - 10.36401/jipo-26-x6
UR  - https://europepmc.org/article/MED/42872036
SN  - 2666-2345
SN  - 2590-017X
ER  -